You just read:

EIP Pharma announces issuance of multiple new patents covering VX-745, a selective p38 MAP kinase alpha inhibitor for Alzheimer's disease and ischemic stroke recovery

News provided by

EIP Pharma, LLC

28 Sep, 2016, 08:00 ET